VEGFA and neoplasm: Blocking of pro-angiogenic factors such as VEGF changes the immune suppressive tumour environment by reducing the frequency of alternatively activated macrophages, myeloid suppressor cells and regulatory T cells while enhancing effector T cell function (51).